Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Healthcare Medical Devices
Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Theralase Technologies Inc.
Bullboard Posts
User Avatar Image
(267)
•••
Comment by LaserStock29on Jul 19, 2020 10:56am
168 Views
Post# 31287290

RE:RE:RE:What the?

RE:RE:RE:What the?Happy sunday looking for all 7 points to be in quarterly.
LaserStock29 wrote:
investclub wrote: Hi Macer yes if this stock closes at or above 23 today it would signify uptrend, however the stock could be reestablishing itself at 23 cents. TLT needs 3 - 5 trading days of more up then down to solidify an uptrend. The expectation of news for RPCCC, restart of enrollment & treatment here in Canada and the extremely slight chance of some US sites announced and yes another Canadian site could be announced should be enough to fuel a rise in share price. We are in hope of a newsletter with some encouraging information and as Quattro74 says no banana in the tailpipe   ...  lol


False... the move into quarterly reports only magnifies the binary nature of the report. 1. Dr. Mandel non gmp gmp for GBM 2. Roswell? 3. Patients treated 2nd time ? 4. Nova Scotia new patients? 5. Cash on Hand 6. TMO agreement update 7. Fast Track. It's absolutely unacceptable for the quarterly not to report to shareholders on all 7 items. UNACCAPTABLE.. I KNOW MANAGEMENT READS THIS BOARD..... The idea this stock needs 3 to 5 days to prove an up or down trend is silly. It's either a big move or nothing.


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities